The Prolactinoma Problem
- 8 February 1979
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 300 (6), 313-315
- https://doi.org/10.1056/nejm197902083000612
Abstract
The secretion of prolactin is tonically inhibited by the hypothalamus, an effect mediated by the release of a prolactin inhibitory factor into the pituitary blood supply.1 Much newly acquired evidence points to dopamine as the principal inhibitory regulator.2 Specific dopamine-containing nerve tracts in the hypothalamus terminate on the blood vessels destined to reach the pituitary, dopamine has been identified in the blood draining the hypothalamus, dopamine receptors have been demonstrated on pituitary cells, and when applied directly to the pituitary, dopamine is highly potent in inhibiting prolactin release. The clinical importance of the dopamine receptor in regulating prolactin secretion is . . .Keywords
This publication has 9 references indexed in Scilit:
- Neural control of prolactin secretion in manPsychoneuroendocrinology, 1978
- PATHOGENESIS OF PROLACTIN-SECRETING PITUITARY ADENOMASThe Lancet, 1978
- Normal Pregnancies after Treatment of Hyperprolactinemia with Bromoergocryptine, Despite Suspected Pituitary TumorsJournal of Clinical Endocrinology & Metabolism, 1978
- Dopamine Levels in Hypophysial Stalk Blood in the Rat are Sufficient to Inhibit Prolactin SecretionIn Vivo*Endocrinology, 1978
- Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumoursBMJ, 1978
- Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrheaAmerican Journal of Obstetrics and Gynecology, 1977
- Galactorrhea: A Study of 235 Cases, Including 48 with Pituitary TumorsNew England Journal of Medicine, 1977
- Ergot-Induced Inhibition of Pituitary Tumor Growth in RatsScience, 1972
- A Radioimmunoassay for Human ProlactinProceedings of the National Academy of Sciences, 1971